LHC Group, Inc. (LHCG) Director Ronald T. Nixon Sells 12,000 Shares

LHC Group, Inc. (NASDAQ:LHCG) Director Ronald T. Nixon sold 12,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total transaction of $1,406,400.00. Following the sale, the director now directly owns 29,100 shares of the company’s stock, valued at approximately $3,410,520. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Shares of NASDAQ:LHCG traded up $0.25 during trading on Wednesday, reaching $118.87. The stock had a trading volume of 216,592 shares, compared to its average volume of 259,736. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. LHC Group, Inc. has a 52 week low of $73.21 and a 52 week high of $122.20. The firm has a market cap of $3.74 billion, a P/E ratio of 33.23, a P/E/G ratio of 2.01 and a beta of 0.87.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The company had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. As a group, sell-side analysts anticipate that LHC Group, Inc. will post 4.3 earnings per share for the current year.

A number of analysts have recently weighed in on the stock. Zacks Investment Research raised shares of LHC Group from a “sell” rating to a “hold” rating in a report on Saturday, May 11th. BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 28th. UBS Group set a $133.00 price target on shares of LHC Group and gave the company a “buy” rating in a research report on Friday, May 10th. Barclays upped their price objective on shares of LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Thursday, March 21st. Finally, Craig Hallum upped their price objective on shares of LHC Group from $93.00 to $114.00 and gave the company a “hold” rating in a research note on Friday, March 1st. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $118.50.

Several large investors have recently bought and sold shares of LHCG. Parallel Advisors LLC boosted its stake in LHC Group by 790.0% during the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after acquiring an additional 237 shares in the last quarter. Sageworth Trust Co bought a new position in LHC Group during the first quarter worth $36,000. Financial Gravity Companies Inc. bought a new position in LHC Group during the fourth quarter worth $49,000. Quadrant Capital Group LLC boosted its stake in LHC Group by 1,045.7% during the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after acquiring an additional 481 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new position in LHC Group during the first quarter worth $68,000. 94.07% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.chaffeybreeze.com/2019/05/22/lhc-group-inc-lhcg-director-ronald-t-nixon-sells-12000-shares.html.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: Using the New Google Finance Tool

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.